Market Place
Sourcing Support
Boehringer, Lilly bring kidney disease test push to Rose Parade
11 Dec 2024 //
FIERCE PHARMA
Torrent Pharma inks agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
05 Dec 2024 //
INDPHARMAPOST
Boehringer Introduces Eurican L4 Vaccine For Leptospirosis
30 Nov 2024 //
PHARMABIZ
Latest Zantac Trial Against Boehringer Ingelheim Ends With Hung Jury
21 Nov 2024 //
REUTERS
Boehringer`s Focus On Health Equity Access To Medicine Upgrade
19 Nov 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim & MTM Vision Partner on Diabetes Vision Loss
13 Nov 2024 //
PHARMABIZ
Boehringer & MTM Initiative to Combat Diabetes-related Vision Loss
12 Nov 2024 //
GLOBENEWSWIRE
Boehringer tops reputation rankings among CV patient groups
31 Oct 2024 //
FIERCE PHARMA
FDA Issues Form 483 to Boehringer Ingelheim Biopharmaceuticals
30 Oct 2024 //
FDA
Boehringer drops obesity drug from Gubra partnership
30 Oct 2024 //
FIERCE BIOTECH
Boehringer Ingelheim And WHO Foundation Promote Equitable Healthcare
15 Oct 2024 //
GLOBENEWSWIRE
Boehringer And Circle Pharma Collaborate On Novel Cancer Treatment
10 Oct 2024 //
BUSINESSWIRE
Boehringer And Circle Pharma Announce Cancer Research
09 Oct 2024 //
BUSINESSWIRE
Zealand And Boehringer Win FDA Breakthrough For Fatty Liver
07 Oct 2024 //
REUTERS
Boehringer Ingelheim Partners With NCD Alliance For Communities
27 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim expands cancer research at its Vienna site
27 Sep 2024 //
PHARMABIZ
Surrozen Earns $10M Milestone in Retinal Diseases Collaboration
24 Sep 2024 //
GLOBENEWSWIRE
Boehringer`s Pulmonary Fibrosis Drug Succeeds In Phase 3, FDA Filing Planned
18 Sep 2024 //
BIOSPACE
Boehringer`s Lung Fibrosis Trial Meets Primary Endpoint
17 Sep 2024 //
FIERCE BIOTECH
Weight-loss market to see 16 new drugs by 2029, report estimates
11 Sep 2024 //
EXPRESSPHARMA
Boehringer`s Zongertinib Shows Promise In HER2 Mutated Lung Cancer
10 Sep 2024 //
PR NEWSWIRE
Boehringer`s Zongertinib Shows Encouraging Profile
09 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim Plans New Geographic Atrophy Treatment
05 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim Acquires Saiba Animal Health for Pet Therapeutics R&D
03 Sep 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim To Present Oncology Research At WCLC
27 Aug 2024 //
GLOBENEWSWIRE
Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline
30 Jul 2024 //
BIOSPACE
CHMP Recommends New Indications For SPEVIGO®
29 Jul 2024 //
GLOBENEWSWIRE
Brainomix and Boehringer Launch Strategic Partnership in Fibrosing Lung Disease
20 Jul 2024 //
PR NEWSWIRE
Boehringer Teams With GoodRx To Offer Discounted Humira Biosimilar
19 Jul 2024 //
FIERCE PHARMA
Boehringer cuts price of Humira biosimilar in bid to build use
19 Jul 2024 //
REUTERS
Boehringer Ingelheim Reports Pipeline Progress In First Half 2024
18 Jul 2024 //
GLOBENEWSWIRE
Boehringer Ingelheim India Grants Funds For Dementia Care Innovation
16 Jul 2024 //
CONTRACT PHARMA
Boehringer Ingelheim produces its own green energy
08 Jul 2024 //
GLOBENEWSWIRE
Boehringer and OSE to advance cancer immunotherapy to clinics
04 Jul 2024 //
PHARMACEUTICAL TECHNOLOGY
Boehringer and Gubra announce clinical development of first-in-class Treatment
01 Jul 2024 //
PRESS RELEASE
GSK et al file appeal to Delaware Zantac order
12 Jun 2024 //
PHARMAPHORUM
Boehringer Ingelheim preps for 2 upcoming oncology launches
10 Jun 2024 //
FIERCE PHARMA
Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening In 64.5%
07 Jun 2024 //
GLOBENEWSWIRE
PhoreMost Achieves Boehringer Ingelheim Alliance Milestone
03 Jun 2024 //
BUSINESSWIRE
AUROBAC`s R&D Strategy, Pipeline, New BI Partnership Program
03 Jun 2024 //
GLOBENEWSWIRE
Boehringer`s COPD, Asthma Inhalers Now Available At $35 For Eligibles
01 Jun 2024 //
PR NEWSWIRE
Economist Impact Study Reveals Outdated Practices Fuel Mental Health Crisis
28 May 2024 //
PRESS RELEASE
Mental Health Crisis Fueled By Outdated Perceptions, Practices: Study
28 May 2024 //
GLOBENEWSWIRE
Chicago jury rules for GSK, Boehringer in key Zantac trial
24 May 2024 //
FIERCE PHARMA
Boehringer And OSE Expand Collaboration For Cancer And Cardio-Renal Therapies
22 May 2024 //
PRESS RELEASE
Boehringer pays OSE $42M to grab new asset, expand into cardio
22 May 2024 //
FIERCE BIOTECH
Regeneron faces new biosimilar threats; an AI biotech lays off staff
22 May 2024 //
BIOPHARMADIVE
Endeavor links IPF drug to improved lung function in phase 2
20 May 2024 //
FIERCE BIOTECH
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
20 May 2024 //
REUTERS
Boehringer Ingelheim unveils its first glo.sustainability publication ‘Imagine’
16 May 2024 //
PRESS RELEASE
CDSCO approves BI’s Spevigo to treat generalized pustular psoriasis flares
15 May 2024 //
PHARMABIZ
Boehringer enlists Cigna`s Quallent to expand Humira biosimilar reach
14 May 2024 //
FIERCE PHARMA
Boehringer Ingelheim Expands Access To Adalimumab Biosimilar Injection
13 May 2024 //
PR NEWSWIRE
Turbulence in Pharma: A Wave of Layoffs Sweeps Through the Industry
07 May 2024 //
BIOSPECTRUM ASIA
Boehringer shares positive data from HORNBILL phase I/IIa study of BI 764524
06 May 2024 //
PHARMABIZ
Boehringer Shares Positive Diabetic Macular Ischemia Study Results
06 May 2024 //
GLOBENEWSWIRE
Walgreens, Boehringer Partner To Improve Clinical Trial Diversity
02 May 2024 //
BUSINESSWIRE
FDA approves Boehringer Ingelheim’s Cyltezo for inflammatory ailments
02 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Boehringer puts a target on Humira, says pushing it off formularies is necessary
02 May 2024 //
ENDPTS
FDA Approves BI`s Citrate-Free Cyltezo, Humira Biosimilar
01 May 2024 //
PR NEWSWIRE
